NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2025
CVR: 34352542
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 50,531,142 and a net result of DKK 28,614,955 compared with DKK 29,275,152 the year before. That is an increase of 0.9% compared with the year before. Equity in the 2025 report amounted to DKK 37,614,955. The solvency ratio was 52.4%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 50,531,142
- Profit/Loss
- DKK 28,614,955
- Equity
- DKK 37,614,955
- Total Assets
- DKK 71,720,072
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 50.5M | 28.6M | 37.6M | 19 |
| 2024 | - | 50.1M | 29.3M | 36.3M | 16 |
| 2023 | - | 45.4M | 11.5M | 22M | 14 |
| 2022 | - | 51.4M | 22.2M | 31.2M | 10 |
| 2021 | - | 55.7M | 35.3M | 41.3M | 8 |
Official annual report
How creditworthy is NORDIC MEDICAL SOLUTIONS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of August 8, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of NORDIC MEDICAL SOLUTIONS ApS.
As of August 8, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of NORDIC MEDICAL SOLUTIONS ApS.
About NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
